EFFECTIVE TARGETING OF MAGNETIC RADIOACTIVE Y-90 MICROSPHERES TO TUMOR-CELLS BY AN EXTERNALLY APPLIED MAGNETIC-FIELD - PRELIMINARY IN-VITRO AND IN-VIVO RESULTS

Magnetic biodegradable poly(lactic acid) microspheres that incorporate both magnetite and the beta-emitter Y-90 were prepared. By applying a directional external magnetic field gradient in excess of 0.02 Tesla/cm across a 96-well plate containing neuroblastoma cells incubated with the Y-90 magnetite loaded microspheres, the radiation dose to the cells could be enhanced or reduced relative to the dose from a uniform loading of the well with Y-90-DTPA. Using the MTT assay, cell survival was measured for the magnetic field directed from above (cell sparing) and from below (cell targeting) the well plate, resulting in 65 +/- 8% or 18 +/- 5% survival respectively. This method was then applied to an in vivo murine tumor model. The biodistribution of intraperitoneally injected magnetic radioactive microspheres, after 24 h in mice, showed that 73 +/- 32% of the radioactivity was found on the subcutaneous tumor that had a rare earth magnet fixed above it. In contrast, the tumor radioactivity with no attached magnet was 6 +/- 4%. Magnetically targeted radiopolymers such as Y-90-microspheres show great promise for regional or intracavitary radiotherapy.